Contact Us

MEETING NEWS

EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jan 3, 2025

CHANGZHOU,China,Jan. 1,2025-- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"),a leading short-distance transportation solutions provider in China,today announced th

CES 2025: Aurafit to Unveil G12 Smartwatch, the Ultimate Companion for A Connected, Active, and Healthy Life

Jan 3, 2025

LAS VEGAS,Jan. 1,2025--AtCES 2025,taking place from January 7-10,Aurafit,a pioneering brand dedicated to providing innovative smart equipment for modern sports enthusiasts and tech-savvy individuals,i

CKGSB Professor Mei Jianping Launches Global Indices Tracking Impressionist, Contemporary, and Chinese Art Markets

Jan 3, 2025

BEIJING,Dec. 31,2024-- CKGSB Finance Professor Mei Jianping has announced the launch of two groundbreaking art indices—the MM Global Impressionist Price Index and the MM Global Contemporary Art Price

DayOne Launches as an Independent Global Data Center Pioneer Following Series B Funding Closure

Jan 3, 2025

SINGAPORE,Jan. 1,2025--DayOne,a leading global data center pioneer,officially launched as an independent group on January 1,2025,ushering in a transformative new era following the successful completi

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

Jan 3, 2025

SHANGHAI,Dec. 31,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections

Jan 3, 2025

SHANGHAI,Jan. 2,2025-- Shanghai MicuRx Pharmaceutical Co.,Ltd. ("MicuRx",688373.SH) announced that MRX-5,its self-developed anti-infection drug,has been granted Orphan Drug Designation (ODD

1 ... 149 150 151 152 153 154 155 ... 353